BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 29382846)

  • 1. A novel human induced pluripotent stem cell blood-brain barrier model: Applicability to study antibody-triggered receptor-mediated transcytosis.
    Ribecco-Lutkiewicz M; Sodja C; Haukenfrers J; Haqqani AS; Ly D; Zachar P; Baumann E; Ball M; Huang J; Rukhlova M; Martina M; Liu Q; Stanimirovic D; Jezierski A; Bani-Yaghoub M
    Sci Rep; 2018 Jan; 8(1):1873. PubMed ID: 29382846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse embryonic stem cell-derived blood-brain barrier model: applicability to studying antibody triggered receptor mediated transcytosis.
    Jezierski A; Huang J; Haqqani AS; Haukenfrers J; Liu Z; Baumann E; Sodja C; Charlebois C; Delaney CE; Star AT; Liu Q; Stanimirovic DB
    Fluids Barriers CNS; 2023 May; 20(1):36. PubMed ID: 37237379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies.
    Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L
    Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An isogenic blood-brain barrier model comprising brain endothelial cells, astrocytes, and neurons derived from human induced pluripotent stem cells.
    Canfield SG; Stebbins MJ; Morales BS; Asai SW; Vatine GD; Svendsen CN; Palecek SP; Shusta EV
    J Neurochem; 2017 Mar; 140(6):874-888. PubMed ID: 27935037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of RARα, RARγ, or RXRα Increases Barrier Tightness in Human Induced Pluripotent Stem Cell-Derived Brain Endothelial Cells.
    Stebbins MJ; Lippmann ES; Faubion MG; Daneman R; Palecek SP; Shusta EV
    Biotechnol J; 2018 Feb; 13(2):. PubMed ID: 28960887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
    Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
    Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Vitro Modeling of Blood-Brain Barrier with Human iPSC-Derived Endothelial Cells, Pericytes, Neurons, and Astrocytes via Notch Signaling.
    Yamamizu K; Iwasaki M; Takakubo H; Sakamoto T; Ikuno T; Miyoshi M; Kondo T; Nakao Y; Nakagawa M; Inoue H; Yamashita JK
    Stem Cell Reports; 2017 Mar; 8(3):634-647. PubMed ID: 28238797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human pluripotent stem cell-derived brain pericyte-like cells induce blood-brain barrier properties.
    Stebbins MJ; Gastfriend BD; Canfield SG; Lee MS; Richards D; Faubion MG; Li WJ; Daneman R; Palecek SP; Shusta EV
    Sci Adv; 2019 Mar; 5(3):eaau7375. PubMed ID: 30891496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accelerated differentiation of human induced pluripotent stem cells to blood-brain barrier endothelial cells.
    Hollmann EK; Bailey AK; Potharazu AV; Neely MD; Bowman AB; Lippmann ES
    Fluids Barriers CNS; 2017 Apr; 14(1):9. PubMed ID: 28407791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling the regulation of insulin transport across the brain endothelial cell.
    Gray SM; Aylor KW; Barrett EJ
    Diabetologia; 2017 Aug; 60(8):1512-1521. PubMed ID: 28601906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimum Transendothelial Electrical Resistance Thresholds for the Study of Small and Large Molecule Drug Transport in a Human in Vitro Blood-Brain Barrier Model.
    Mantle JL; Min L; Lee KH
    Mol Pharm; 2016 Dec; 13(12):4191-4198. PubMed ID: 27934481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.
    Georgieva JV; Goulatis LI; Stutz CC; Canfield SG; Song HW; Gastfriend BD; Shusta EV
    FASEB J; 2020 Sep; 34(9):12549-12564. PubMed ID: 32960493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An isogenic neurovascular unit model comprised of human induced pluripotent stem cell-derived brain microvascular endothelial cells, pericytes, astrocytes, and neurons.
    Canfield SG; Stebbins MJ; Faubion MG; Gastfriend BD; Palecek SP; Shusta EV
    Fluids Barriers CNS; 2019 Aug; 16(1):25. PubMed ID: 31387594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryopreservation of Brain Endothelial Cells Derived from Human Induced Pluripotent Stem Cells Is Enhanced by Rho-Associated Coiled Coil-Containing Kinase Inhibition.
    Wilson HK; Faubion MG; Hjortness MK; Palecek SP; Shusta EV
    Tissue Eng Part C Methods; 2016 Dec; 22(12):1085-1094. PubMed ID: 27846787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.
    Simonneau C; Duschmalé M; Gavrilov A; Brandenberg N; Hoehnel S; Ceroni C; Lassalle E; Kassianidou E; Knoetgen H; Niewoehner J; Villaseñor R
    Fluids Barriers CNS; 2021 Sep; 18(1):43. PubMed ID: 34544422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of Cancer-Targeting Alkylphosphocholine Analogue Permeability Characteristics Using a Human Induced Pluripotent Stem Cell Blood-Brain Barrier Model.
    Clark PA; Al-Ahmad AJ; Qian T; Zhang RR; Wilson HK; Weichert JP; Palecek SP; Kuo JS; Shusta EV
    Mol Pharm; 2016 Sep; 13(9):3341-9. PubMed ID: 27421304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo methods for assessing FcRn-mediated reverse transcytosis across the blood-brain barrier.
    Caram-Salas N; Boileau E; Farrington GK; Garber E; Brunette E; Abulrob A; Stanimirovic D
    Methods Mol Biol; 2011; 763():383-401. PubMed ID: 21874466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell line.
    Ozgür B; Puris E; Brachner A; Appelt-Menzel A; Oerter S; Balzer V; Holst MR; Christiansen RF; Hyldig K; Buckley ST; Kristensen M; Auriola S; Jensen A; Fricker G; Nielsen MS; Neuhaus W; Brodin B
    Fluids Barriers CNS; 2023 Dec; 20(1):96. PubMed ID: 38115090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress and new challenges in modeling of human pluripotent stem cell-derived blood-brain barrier.
    Yan L; Moriarty RA; Stroka KM
    Theranostics; 2021; 11(20):10148-10170. PubMed ID: 34815809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of an in Vitro Human Blood-Brain Barrier Model Derived from Induced Pluripotent Stem Cells and Comparison to a Porcine Cell-Based System.
    Di Marco A; Vignone D; Gonzalez Paz O; Fini I; Battista MR; Cellucci A; Bracacel E; Auciello G; Veneziano M; Khetarpal V; Rose M; Rosa A; Gloaguen I; Monteagudo E; Herbst T; Dominguez C; Muñoz-Sanjuán I
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.